NCT05749289 2024-03-29
Application of Al18F-octreotide PET/CT in Neuroendocrine Tumor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2/3 Recruiting
Clinical Trials
4 trialsNCT04552847 2022-02-17
Al18F-NOTA-octreotide PET Imaging in Neuroendocrine Tumors
Universitaire Ziekenhuizen KU Leuven
Phase 2/3 Completed
NCT03883776 2020-09-09
Al18F-NOTA-octreotide PET Imaging of the Somatostatin Receptor in Neuroendocrine Tumors
Universitaire Ziekenhuizen KU Leuven
Phase 1 Completed
NCT03511768 2018-04-30
A Study of 18F-AlF-NOTA-octreotide PET/CT for Imaging Neuroendocrine Neoplasms
Xiangya Hospital of Central South University
Phase 1/2 Unknown